Celltrion
068270.KS
#771
Rank
โ‚ฌ25.86 B
Marketcap
118,22ย โ‚ฌ
Share price
1.48%
Change (1 day)
7.42%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): 1,65ย โ‚ฌ

According to Celltrion 's latest financial reports the company's current EPS (TTM) is 1,64ย โ‚ฌ. an increase over its 2024 EPS that were of 1,07ย โ‚ฌ.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
20252,81ย โ‚ฌ163.66%
20241,07ย โ‚ฌ-53.73%
20232,31ย โ‚ฌ-2.08%
20222,36ย โ‚ฌ-11.72%
20212,67ย โ‚ฌ2.03%
20202,62ย โ‚ฌ82.8%
20191,43ย โ‚ฌ18.31%
20181,21ย โ‚ฌ-36.33%
20171,90ย โ‚ฌ161.25%
20160,73ย โ‚ฌ2.86%
20150,71ย โ‚ฌ17.84%
20140,60ย โ‚ฌ5.87%
20130,57ย โ‚ฌ-70.85%
20121,94ย โ‚ฌ134.09%
20110,83ย โ‚ฌ43.59%
20100,58ย โ‚ฌ74.49%
20090,33ย โ‚ฌ317.8%
20080,07932ย โ‚ฌ-71.7%
20070,28ย โ‚ฌ